SkylineDx has published a new study marking a “significant advancement” in understanding and identifying high-risk multiple ...

Pulnovo Medical has closed a Series C financing round, securing around $100m for progressing the company's worldwide trials.

UCSD has initiated a clinical trial to assess Nexalin Technology's Halo Clarity device for treating mTBI and PTSD.

Demetra Holding has acquired a 51% stake in Swiss company GetSet Surgical to expand its offerings within the spine sector.

BillionToOne has reported outcomes from a US clinical study of its non-invasive prenatal test (NIPT) for determining the ...

Speaking at the Health Care Excellence Through Technology show, Richard Leese detailed how the EPR system has been extended ...

GE HealthCare has announced a leadership transition for its China operations, with Will Song to succeed Yihao Zhang as new ...

Traditional screening methods rely on biochemical tests, such as tandem mass spectrometry, which detect metabolic imbalances ...

Biomerica has received CE-marking for its food intolerance tests tailored for ulcerative colitis and Crohn's disease, under ...

Following a hefty raise by Beta Bionics last month, Kestra’s IPO means medtech has enjoyed a strong 2025 start for listings.

CollPlant has announced the expansion of its distribution network for VergenixSTR, in European and Asian markets.

UK-based OrganOx has received $142m in primary and secondary equity financing to propel the growth of its metra platform ...